long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay
Angelo Auricchio, MD, PhD*,*,
Christoph Stellbrink, MD ,
Stefan Sack, MD¶,
Michael Block, MD||,
J.ürgen Vogt, MD**,
Patricia Bakker, MD ,
Christof Huth, MD ,
Friedrich Schöndube, MD ,
Ulrich Wolfhard, MD#,
Dirk Böcker, MD||,
Olaf Krahnefeld, MD**,
Hans Kirkels, MD, PhD Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group
* CardiologyMagdeburg, Germany
Cardiac Surgery, University Hospital, Magdeburg, Germany
Cardiology, Magdeburg, Germany
Cardiovascular Surgery, University Hospital RWTH, Aachen, Germany
|| Department of Cardiology, University Hospital, Münster, Germany
¶ Cardiology, Münster, Germany
# Cardiovascular Surgery, University Hospital, Essen, Germany
** Heart Center, Bad Oeynhausen, Germany
 Cardiac Surgery, Essen, Germany
 Cardiology, University Hospital, Utrecht, The Netherlands

View larger version (29K):
[in a new window]
|
Figure 1 Flow chart of the Pacing Therapies in Congestive Heart Failure study, which was conducted between August 1995 and October 1998. CRT = cardiac resynchronization therapy; NYHA = New York Heart Association; SCD = sudden cardiac death; VT = ventricular tachycardia.
|
|
|